The Product Development Team at Endeavor Biomedicines focuses on advancing their Hedgehog inhibitor for Idiopathic Pulmonary Fibrosis through clinical trials and toward market approval. This team coordinates chemistry, manufacturing, and controls (CMC), navigates regulatory requirements, and strategizes business development to ensure the successful commercialization of their therapeutic candidate.